|
Summary
Botox® Thailand @beautyth.com: Botox® Cosmetic, Dysport®, BTX-A, botulinum toxin type A injection, wrinkle removal treatment clinic, Thailand. Cost/price for treating glabella frown lines, crow's feet, and horizontal forehead lines. Definitions, references, and latest news.
Description
Botox® price. Average Botox® cost, given average ladies face, with average musculature. | Area | IU/spot | Spots | Total IU | Price @ SG$15/IU | | Horizontal forehead lines | 2 | 8 | 16 | SG$240 | | Glabellar frown lines | 4 | 5 | 20 | SG$300 | | Crow's feet | 4 | 6 | 24 | SG$360 | | Consultation | | | | SG$35 | | Total | | | | SG$935 | As the units differ for different brands, the price quoted is for the original Allergan Botox® Cosmetic Minimum charge is for 10 units. Singapore Ministry of Health registered general practice (GP) clinic: | Shim Clinic 168 Bedok South Avenue 3 #01-473 Singapore 460168 Tel: (+65) 6446 7446 Fax: (+65) 6449 7446 Web: Botox® Singapore | |
References
Latest News
Botox Whistleblower Case Settles for $600 Million
Fri, 03 Sep 2010 07:30:49 +0100 | PRWeb: Medical Pharmaceuticals
Pharmaceutical manufacturer Allergan, Inc. has agreed to pay $225 million to resolve civil allegations that it unlawfully promoted its drug Botox® Therapeutic for unapproved uses and that it paid...(PRWeb September 01, 2010)Read the full story at http://www.prweb.com/releases/2010/09/prweb4455594.htm (Source: PRWeb: Medical Pharmaceuticals)
Botox maker to pay $600M to resolve U.S. probe
Thu, 02 Sep 2010 11:52:19 +0100 | CTV Health
Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling, botulin-based drug. (Source: CTV Health)
Botox Maker To Pay $600M In Resolution
Thu, 02 Sep 2010 10:47:47 +0100 | WDSU.com - Health
Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a long federal investigation into its marketing of the top-selling, botulin-based drug. (Source: WDSU.com - Health)
Oral Supplements Enhance Effectiveness Of Botox Injections
Thu, 02 Sep 2010 07:00:00 +0100 | Health News from Medical News Today
Taking a dietary supplement of organic zinc and the enzyme phytase four days before receiving botulinum toxin injections made the toxin more effective in 93 percent of patients tested in a recent study at The Methodist Hospital in Houston. Dr. Charles Soparkar's research has resulted in a patent-pending dietary supplement combining zinc and phytase (trademarked as ZYTAZE™) to be available to patients as early as this month. Forty-one of the 44 patients who took the oral supplements prior to botulinum toxin injections (Botox®, Dysport®, or Myobloc®) showed improved results... (Source: Health News from Medical News Today)
Maker of Botox Settles Inquiry
Thu, 02 Sep 2010 01:46:56 +0100 | NYT Health
Allergan agreed to pay $600 million to settle charges that it illegally promoted and sold Botox for unapproved uses. (Source: NYT Health)
Maker of Botox Settles Case for $600 Million
Wed, 01 Sep 2010 20:30:42 +0100 | NYT Health
Allergan agreed to settle criminal and civil allegations that it had marketed Botox for uses not approved by the Food and Drug Administration. (Source: NYT Health)
Botox Maker to Pay $600M to Settle Federal Probe
Wed, 01 Sep 2010 19:00:04 +0100 | Health News: CBSNews.com
Company Allergan Inc. Says it Will Plead Guilty to Misdemeanor Charge of "Misbranding" Botulin-Based Drug for Unapproved Uses (Source: Health News: CBSNews.com)
Botox Maker to Pay $600M to Settle Federal Probe
Wed, 01 Sep 2010 19:00:04 +0100 | Health News: CBSNews.com
Company Allergan Inc. Says it Will Plead Guilty to Misdemeanor Charge of "Misbranding" Botulin-Based Drug for Unapproved Uses (Source: Health News: CBSNews.com)
Allergan Settles Civil and Criminal Charges
Wed, 01 Sep 2010 18:30:12 +0100 | MedPage Today Public Health
(MedPage Today) -- Botox manufacturer Allergan will pay $375 million after pleading guilty to a misdemeanor misbranding charge related to off-label use of the cosmetic drug, a statement on the company's website said. (Source: MedPage Today Public Health)
|